BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12067490)

  • 1. Immunohistochemical features of paragangliomas.
    Pávai Z; Orosz Z; Horváth E; Seres-Sturm L; Jung J
    J Cell Mol Med; 2001; 5(3):311-6. PubMed ID: 12067490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catecholamine-secreting paraganglioma of glomus jugulare region.
    Kremer R; Michel RP; Posner B; Wang NS; Lafond GP; Crawhall JC
    Am J Med Sci; 1989 Jan; 297(1):46-8. PubMed ID: 2536519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histological features, Ki-67 and Bcl-2 immunohistochemical expression and their correlation with the aggressiveness of pheochromocytomas.
    Jovanovic R; Kostadinova-Kunovska S; Bogoeva B; Spasevska L; Petrusevska G
    Prilozi; 2012; 33(2):23-40. PubMed ID: 23425867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinguishing clear cell renal cell carcinoma, retroperitoneal paraganglioma, and adrenal cortical lesions on limited biopsy material: utility of immunohistochemical markers.
    Lapinski JE; Chen L; Zhou M
    Appl Immunohistochem Mol Morphol; 2010 Oct; 18(5):414-21. PubMed ID: 20861762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paragangliomas: assessment of prognosis by histologic, immunohistochemical, and ultrastructural techniques.
    Kliewer KE; Wen DR; Cancilla PA; Cochran AJ
    Hum Pathol; 1989 Jan; 20(1):29-39. PubMed ID: 2912871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracranial catecholamine secreting paragangliomas.
    Nelson MD; Kendall BE
    Neuroradiology; 1987; 29(3):277-82. PubMed ID: 3039399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of biomolecular markers (Ki-67, PCNA, Bcl-2, BAX, BclX, VEGF) in breast tumors.
    Kushlinskii NE; Orinovskii MB; Gurevich LE; Kazantseva IA; Talaeva ShZh; Shirokii VP; Ermilova VD; Dvorova EK; Ozherelev AS
    Bull Exp Biol Med; 2004 Feb; 137(2):182-5. PubMed ID: 15273770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of neuropeptides in malignant paragangliomas: an immunohistochemical study.
    Linnoila RI; Lack EE; Steinberg SM; Keiser HR
    Hum Pathol; 1988 Jan; 19(1):41-50. PubMed ID: 2447010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and extent of cytokeratin expression in paraganglioma: an immunohistochemical study of 60 cases from 5 anatomic sites and review of the literature.
    Dermawan JK; Mukhopadhyay S; Shah AA
    Hum Pathol; 2019 Nov; 93():16-22. PubMed ID: 31442521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of putative molecular biomarkers in abdominal and retroperitoneal leiomyosarcomas.
    Shpitz B; Tiomkin V; Bomstein Y; Gralkin M; Buklan H; Bernheim J; Klein E
    Eur J Surg Oncol; 2001 Mar; 27(2):203-8. PubMed ID: 11289760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pigmented extraadrenal paragangliomas. A clinicopathologic and immunohistochemical study of five cases.
    Moran CA; Albores-Saavedra J; Wenig BM; Mena H
    Cancer; 1997 Jan; 79(2):398-402. PubMed ID: 9010114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine in paragangliomas of the glomus jugulare.
    Azzarelli B; Felten S; Muller J; Miyamoto R; Purvin V
    Laryngoscope; 1988 May; 98(5):573-8. PubMed ID: 2834616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 and related proteins in epithelial ovarian cancer.
    Sengupta PS; McGown AT; Bajaj V; Blackhall F; Swindell R; Bromley M; Shanks JH; Ward T; Buckley CH; Reynolds K; Slade RJ; Jayson GC
    Eur J Cancer; 2000 Dec; 36(18):2317-28. PubMed ID: 11094305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extra-adrenal paraganglioma and pulmonary chondroma: a case report and review of the literature.
    Keyhani-Rofagha S; O'Dorisio TM; Lucas JG; Fontana MB; Tuttle SE
    J Surg Oncol; 1987 Jun; 35(2):89-95. PubMed ID: 2884350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KI-67 AND hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma.
    Elder EE; Xu D; Höög A; Enberg U; Hou M; Pisa P; Gruber A; Larsson C; Bäckdahl M
    Mod Pathol; 2003 Mar; 16(3):246-55. PubMed ID: 12640105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [S100 protein positive sustentacular cells in pulmonary carcinoids and thoracic paragangliomas: differential diagnostic and prognostic evaluation].
    Warth A; Krysa S; Zahel T; Hoffmann H; Schirmacher P; Schnabel PA; Herpel E
    Pathologe; 2010 Sep; 31(5):379-84. PubMed ID: 20567830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical expression of Ki-67 antigen, cox-2 and Bax/Bcl-2 in prostate cancer; prognostic value in biopsies and radical prostatectomy specimens.
    Rubio J; Ramos D; López-Guerrero JA; Iborra I; Collado A; Solsona E; Almenar S; Llombart-Bosch A
    Eur Urol; 2005 Nov; 48(5):745-51. PubMed ID: 16139948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paragangliomas of the head and neck: ultrastructural and immunohistochemical analysis.
    Warren WH; Lee I; Gould VE; Memoli VA; Jao W
    Ultrastruct Pathol; 1985; 8(4):333-43. PubMed ID: 3001985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine-Secreting Paraganglioma in the Retroperitoneum.
    Matsuda Y; Kimura N; Yoshimoto T; Sekiguchi Y; Tomoishi J; Kasahara I; Hara Y; Ogawa Y
    Endocr Pathol; 2017 Mar; 28(1):36-40. PubMed ID: 27743246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Bcl-2, but not Bax, correlates with estrogen receptor status and tumor proliferation in invasive breast carcinoma.
    Yang Q; Sakurai T; Jing X; Utsunomiya H; Shan L; Nakamura Y; Nakamura M; Oura S; Suzuma T; Yoshimura G; Umemura T; Kokawa Y; Kakudo K
    Pathol Int; 1999 Sep; 49(9):775-80. PubMed ID: 10504548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.